Anaerobe-targeted antibiotic therapy in the neonatal intensive care unit
Anaerobe-targeted antibiotic therapy in the neonatal intensive care unit

Anaerobe-targeted antibiotic therapy in the neonatal intensive care unit

J Pediatric Infect Dis Soc. 2024 Oct 11:piae109. doi: 10.1093/jpids/piae109. Online ahead of print.

ABSTRACT

Anaerobe-targeted antibiotic (ATA) therapy may adversely impact the developing neonatal microbiome. We describe utilization patterns, potential indications, and related outcomes of ATA therapy in neonatal intensive care units across the US over 13 years. While overall antibiotic use decreased, ATA use was unchanged. Potentially associated indications were inconsistent.

PMID:39392923 | DOI:10.1093/jpids/piae109